Open AccessModern biomarker cardiotrophin-1 in the diagnosis of myocardial diastolic function in men with essential hypertension
Author(s) -
М.О. Матохнюк,
V. M. Zhebel,
L. V. Kulchevich,
O. Shevchuk
Publication year - 2020
Publication title -
vìsnik vìnnicʹkogo nacìonalʹnogo medičnogo unìversitetu
Language(s) - English
Resource type - Journals
eISSN - 2522-9354
pISSN - 1817-7883
DOI - 10.31393/reports-vnmedical-2020-24(3)-15
Subject(s) - medicine , heart failure , cardiology , asymptomatic , essential hypertension , diastole , urotensin ii , genotyping , biomarker , gene , blood pressure , genotype , receptor , biology , biochemistry
Annotation. The aim of the study was to improve the diagnosis of myocardial diastolic function in men with essential hypertension and chronic heart failure with different variants of the cardiotrophin-1 gene. 100 people aged 40–60 were examined: 50 men with asymptomatic essential hypertension and 50 men with essential hypertension complicated by chronic heart failure. Genotyping of the cardiotrophin-1 gene was performed by polymerase chain reaction. Determination of the concentration of cardiotrophin-1 was performed by enzyme-linked immunosorbent assay. Structural and functional parameters of the myocardium were evaluated using ultrasound of the heart. Mathematical processing of the material was performed on a personal computer using the standard statistical package SPSS 10. It was found that in persons with essential hypertension and chronic heart failure, carriers of the GA + AA variant of the cardiotrophin-1 gene (rs8046707) have significantly higher plasma peptide levels with diastolic dysfunction (p <0.05).